methyl 5-aminolevulinate has been researched along with Pruritus in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Lecamwasam, K; Levell, NJ; Skellett, AM | 1 |
Aguilera, P; Combalia, A; Ferrando, J; Fustà -Novell, X; Mascaró, JM; Morgado-Carrasco, D; Podlipnik, S | 1 |
Bayat, A; Morris, J; Thomas, G; Ud-Din, S | 1 |
Bojar, RA; Fernandez, C; Goulden, V; Stables, GI; Williams, J; Yung, A | 1 |
2 review(s) available for methyl 5-aminolevulinate and Pruritus
Article | Year |
---|---|
Segmental porokeratosis responding to methyl aminolevulinate photodynamic therapy.
Topics: Aftercare; Aged; Aminolevulinic Acid; Humans; Male; Pain; Photochemotherapy; Porokeratosis; Pruritus; Treatment Outcome | 2020 |
Porokeratosis ptychotropica responding to photodynamic therapy: An alternative treatment for a refractory disease.
Topics: Aminolevulinic Acid; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porokeratosis; Pruritus; Retreatment | 2017 |
1 trial(s) available for methyl 5-aminolevulinate and Pruritus
Article | Year |
---|---|
Microbiological effect of photodynamic therapy (PDT) in healthy volunteers: a comparative study using methyl aminolaevulinate and hexyl aminolaevulinate cream.
Topics: Adolescent; Adult; Aminolevulinic Acid; Double-Blind Method; Erythema; Female; Humans; Hyperpigmentation; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Propionibacterium; Pruritus; Skin | 2007 |
1 other study(ies) available for methyl 5-aminolevulinate and Pruritus
Article | Year |
---|---|
Photodynamic therapy: an innovative approach to the treatment of keloid disease evaluated using subjective and objective non-invasive tools.
Topics: Aminolevulinic Acid; Collagen; Female; Hemoglobins; Humans; Keloid; Male; Melanins; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Pruritus; Treatment Outcome | 2013 |